Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant Therapy

Michelakos, T; Cai, L; Villani, V; Sabbatino, F; Kontos, F; Fernandez-del Castillo, C; Yamada, T; Neyaz, A; Taylor, MS; Deshpande, V; Kurokawa, T; Ting, DT; Qadan, M; Weekes, CD; Allen, JN; Clark, JW; Hong, TS; Ryan, DP; Wo, JY; Warshaw, AL; Lillemoe, KD; Ferrone, S; Ferrone, CR

Ferrone, CR (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, 15 Parkman St, Boston, MA 02114 USA.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021; 113 (2): 182

Abstract

Background: Neoadjuvant folinic acid, fluorouracil, irinotecan, and oxaliplatin (FOLFIRINOX) and chemoradiation have been used to downstage borderline......

Full Text Link